Effectiveness of St John's wort in major depression: a randomized controlled trial.
Richard C. Shelton(University of Alabama at Birmingham), Uriel Halbreich(University at Buffalo, State University of New York), Paul J. Goodnick(University of Miami), R. Bruce Lydiard(University of South Carolina), David J. Hellerstein(Yeshiva University), David L. Dünner, James Russell(Wellcome/MRC Cambridge Stem Cell Institute), Michael E. Thase(Veterans Health Administration), Alan J. Gelenberg(University of Arizona), Robert Gallop(California University of Pennsylvania), Gabor I. Keitner(Brown University), Linda Todd(Vanderbilt University), Martín Keller(University of Basel), Robert M. A. Hirschfeld(The University of Texas Medical Branch at Galveston), Stephen M. Stahl(Champalimaud Foundation)
Cited by 385
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
|Archives of General Psychiatry|2007|2.4k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k
Frontiers of cognitive therapy
|General Hospital Psychiatry|1997|1.1k